Publications
- Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE2021 | First Faculty of Medicine
- Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers2019 | First Faculty of Medicine, Third Faculty of Medicine
- Is Preoperative Bone Scintigraphy in Early Stage of Breast Cancer Is Preoperative Bone Scintigraphy in Early Stage of Breast Cancer Is preoperative bone scintigraphy in early stage of breast cancer T1N0 Indicated and Meaningful?2013 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The results of the therapy in patients with breast made saving power for breast cancer patients operated at 1 Surgical Clinic, 1st Faculty of Medicine2012 | First Faculty of Medicine
- Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene2010 | First Faculty of Medicine
- Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (H) in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: KATHERINE subgroup analysisPublication without faculty affiliation
- Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic2023 | First Faculty of Medicine
- Preservation of fertility in young patients with breast cancer, including BRCA1, BRCA2 mutation carriers2023 | First Faculty of Medicine
- Trastuzumab deruxtecan in the treatment of patients with metastatic HER2‑low breast cancer2023 | First Faculty of Medicine
- Ultrasound appearance and targeted therapy of symptomatic neural lesions in the breast and chest wall after breast cancer surgery2023 | First Faculty of Medicine
Loading network view...
